The Value of Evidence in the Decision-Making Process for Reimbursement of Pharmacogenetic Dosing of Warfarin

Background After early clinical trials that evaluated pharmacogenetic (PG) algorithms, many healthcare payers were reluctant to cover this technology and, consequently, PG dosing of warfarin could not be translated into clinical practice. Objective The aim of this study was to estimate the value of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of cardiovascular drugs : drugs, devices, and other interventions devices, and other interventions, 2017-10, Vol.17 (5), p.399-408
Hauptverfasser:	Janzic, Andrej, Locatelli, Igor, Kos, Mitja
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Cardiology Clinical trials Decision making Expected values Medicine Medicine & Public Health Original Research Article Pharmacology/Toxicology Pharmacotherapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!